{"retracted":false,"update":{"timestamp":1257984000000,"doi":"10.1371/annotation/e57b4610-9029-48db-9d57-5cc0fa35b8ac","type":"correction"},"doi":"10.1371/journal.pone.0007520","journal":"PLoS ONE","publisher":"Public Library of Science (PLoS)","title":"Correction: Imatinib and Nilotinib Reverse Multidrug Resistance in Cancer Cells by Inhibiting the Efflux Activity of the MRP7 (ABCC10)"}
